As of August 28, 2026, Recursion Pharmaceuticals, Inc. (RXRX) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Recursion Pharmaceuticals, Inc. has a market capitalization of $1.77B, 535.34M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $300.00M.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
📊Float Risk—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise
model 18%
• Active ATM program with $300M remaining capacity
Market Data
Market Cap$1.77B
Shares Outstanding535.34M
FloatN/A
Cash$545.68M
Debt$723.0K
Short InterestN/A
Institutional Holdings
10 institutional holders · 226.35M shares
#1
Vanguard Group Inc
47.19M shares
#2
Blackrock Inc.
38.87M shares
#3
ARK Investment Management, LLC
37.32M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest180.77M
Days to Cover9.3
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2022-12-31
4
INSIDER TRANSACTION
2026-07-02
4
INSIDER TRANSACTION
2026-06-22
4
INSIDER TRANSACTION
2026-06-22
4
INSIDER TRANSACTION
2026-06-22
Full SEC filing analysis available with free account
→
Factual RXRX Dilution Snapshot
Recursion Pharmaceuticals, Inc. (RXRX) has a DilutionScore of 37/100, rated Medium dilution risk. Score date: August 28, 2026.
- Stored ATM program remaining capacity: $300.0M.
- Recent SEC activity tracked for RXRX: 4 on 2026-07-02; 4 on 2026-06-22; 4 on 2026-06-22.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track RXRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RXRX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.
More Research for RXRX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.